Tybamate

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 23:56, 23 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Tybamate
Clinical data
ATC code
  • none
Identifiers
  • [2-(carbamoyloxymethyl)-2-methylpentyl] N-butylcarbamate
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.022.050 Edit this at Wikidata
Chemical and physical data
FormulaC13H26N2O4
Molar mass274.361 g·mol−1
3D model (JSmol)
  • CCCCNC(=O)OCC(C)(CCC)COC(=O)N
  • InChI=1S/C13H26N2O4/c1-4-6-8-15-12(17)19-10-13(3,7-5-2)9-18-11(14)16/h4-10H2,1-3H3,(H2,14,16)(H,15,17) ☒N
  • Key:PRBORDFJHHAISJ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Tybamate (INN; Solacen, Tybatran, Effisax) is an anxiolytic of the carbamate family.[1] It is a prodrug for meprobamate in the same way as the better known drug carisoprodol. It has liver enzyme inducing effects similar to those of phenobarbital but much weaker.[2]

References

  1. ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. p. 1077. ISBN 978-3-88763-075-1.
  2. ^ Segelman FH, Kelton E, Terzi RM, Kucharczyk N, Sofia RD. The comparative potency of phenobarbital and five 1,3-propanediol dicarbamates for hepatic cytochrome P450 induction in rats. Research Communications in Chemical Pathology and Pharmacology. 1985 Jun;48(3):467-70.